193 related articles for article (PubMed ID: 21309118)
1. Metabotropic glutamate receptors: their therapeutic potential in anxiety.
Spooren W; Lesage A; Lavreysen H; Gasparini F; Steckler T
Curr Top Behav Neurosci; 2010; 2():391-413. PubMed ID: 21309118
[TBL] [Abstract][Full Text] [Related]
2. mGlu5 receptor antagonists: a novel class of anxiolytics?
Spooren W; Gasparini F
Drug News Perspect; 2004 May; 17(4):251-7. PubMed ID: 15334174
[TBL] [Abstract][Full Text] [Related]
3. Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders.
Spooren W; Ballard T; Gasparini F; Amalric M; Mutel V; Schreiber R
Behav Pharmacol; 2003 Jul; 14(4):257-77. PubMed ID: 12838033
[TBL] [Abstract][Full Text] [Related]
4. Novel metabotropic glutamate receptor 4 and glutamate receptor 8 therapeutics for the treatment of anxiety.
Raber J; Duvoisin RM
Expert Opin Investig Drugs; 2015 Apr; 24(4):519-28. PubMed ID: 25518990
[TBL] [Abstract][Full Text] [Related]
5. Metabotropic glutamate receptor 7: at the interface of cognition and emotion.
O'Connor RM; Finger BC; Flor PJ; Cryan JF
Eur J Pharmacol; 2010 Aug; 639(1-3):123-31. PubMed ID: 20371242
[TBL] [Abstract][Full Text] [Related]
6. Glutamate metabotropic receptors as targets for drug therapy in epilepsy.
Moldrich RX; Chapman AG; De Sarro G; Meldrum BS
Eur J Pharmacol; 2003 Aug; 476(1-2):3-16. PubMed ID: 12969743
[TBL] [Abstract][Full Text] [Related]
7. The metabotropic glutamate receptors: potential drug targets for the treatment of anxiety disorders?
Pitsikas N
Eur J Pharmacol; 2014 Jan; 723():181-4. PubMed ID: 24361306
[TBL] [Abstract][Full Text] [Related]
8. Actions of Group I and Group II metabotropic glutamate receptor ligands on 5-hydroxytryptamine release in the rat cerebral cortex in vivo: differential roles in the regulation of central serotonergic neurotransmission.
Lee JJ; Croucher MJ
Neuroscience; 2003; 117(3):671-9. PubMed ID: 12617971
[TBL] [Abstract][Full Text] [Related]
9. Metabotropic glutamate receptors as therapeutic targets in Parkinson's disease: An update from the last 5 years of research.
Litim N; Morissette M; Di Paolo T
Neuropharmacology; 2017 Mar; 115():166-179. PubMed ID: 27055772
[TBL] [Abstract][Full Text] [Related]
10. Targeting of metabotropic glutamate receptors for the treatment of schizophrenia.
Chaki S; Hikichi H
Curr Pharm Des; 2011; 17(2):94-102. PubMed ID: 21355835
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological profiling of native group II metabotropic glutamate receptors in primary cortical neuronal cultures using a FLIPR.
Sanger H; Hanna L; Colvin EM; Grubisha O; Ursu D; Heinz BA; Findlay JD; Vivier RG; Sher E; Lodge D; Monn JA; Broad LM
Neuropharmacology; 2013 Mar; 66():264-73. PubMed ID: 22659090
[TBL] [Abstract][Full Text] [Related]
12. New therapeutic frontiers for metabotropic glutamate receptors.
Niswender CM; Jones CK; Conn PJ
Curr Top Med Chem; 2005; 5(9):847-57. PubMed ID: 16178730
[TBL] [Abstract][Full Text] [Related]
13. Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs.
Bruno V; Battaglia G; Copani A; D'Onofrio M; Di Iorio P; De Blasi A; Melchiorri D; Flor PJ; Nicoletti F
J Cereb Blood Flow Metab; 2001 Sep; 21(9):1013-33. PubMed ID: 11524608
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in non-competitive mGlu5 receptor antagonists and their potential therapeutic applications.
Slassi A; Isaac M; Edwards L; Minidis A; Wensbo D; Mattsson J; Nilsson K; Raboisson P; McLeod D; Stormann TM; Hammerland LG; Johnson E
Curr Top Med Chem; 2005; 5(9):897-911. PubMed ID: 16178734
[TBL] [Abstract][Full Text] [Related]
15. Targeting metabotropic glutamate receptors for the treatment of depression and other stress-related disorders.
Dogra S; Conn PJ
Neuropharmacology; 2021 Sep; 196():108687. PubMed ID: 34175327
[TBL] [Abstract][Full Text] [Related]
16. Allosteric modulators of group I metabotropic glutamate receptors: novel subtype-selective ligands and therapeutic perspectives.
Gasparini F; Kuhn R; Pin JP
Curr Opin Pharmacol; 2002 Feb; 2(1):43-9. PubMed ID: 11786307
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potential of group III metabotropic glutamate receptors.
Lavreysen H; Dautzenberg FM
Curr Med Chem; 2008; 15(7):671-84. PubMed ID: 18336281
[TBL] [Abstract][Full Text] [Related]
18. Metabotropic glutamate receptors in the control of mood disorders.
Witkin JM; Marek GJ; Johnson BG; Schoepp DD
CNS Neurol Disord Drug Targets; 2007 Apr; 6(2):87-100. PubMed ID: 17430147
[TBL] [Abstract][Full Text] [Related]
19. Activation of Group II Metabotropic Glutamate Receptors Promotes LTP Induction at Schaffer Collateral-CA1 Pyramidal Cell Synapses by Priming NMDA Receptors.
Rosenberg N; Gerber U; Ster J
J Neurosci; 2016 Nov; 36(45):11521-11531. PubMed ID: 27911756
[TBL] [Abstract][Full Text] [Related]
20. [Metabotropic glutamate receptors: new molecular targets in the treatment of neurological and psychiatric diseases].
Luján-Miras R
Rev Neurol; 2005 Jan 1-15; 40(1):43-53. PubMed ID: 15696426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
